Lipid Metabolism in Diseases

15 April 2022
20 April 2022

Edited by: Professor Xiangdong Wang, Editor-in-Chief of Clinical and Translational Medicine

Table of Contents

Open Access

New focuses on roles of communications between endoplasmic reticulum and mitochondria in identification of biomarkers and targets

New focuses on roles of communications between endoplasmic reticulum and mitochondria in identification of biomarkers and targets

Highlights

1. The ER-Mt interactions are the important part of intracellular communication responsible for cell metabolism, development and death in the biological processes.

2. The ER-Mt regulations contribute to molecular mechanisms of diseases and vary among diseases, severities, stages and sensitivities to therapies.

3. The molecular signals during ER-Mt communication can be potential sources to discover and develop biology-, disease- and therapy-specific biomarkers and targets.

Open Access

Adipose-specific ATGL ablation reduces burn injury-induced metabolic derangements in mice

Adipose-specific ATGL ablation reduces burn injury-induced metabolic derangements in mice

  • A severe burn injury and its associated hypermetabolic response induces adipocyte dysfunction, fat catabolism, elevated fatty acids in the circulation and hepatic steatosis.
  • Adipose triglyceride lipase (ATGL) plays a central role in adipose lipolysis and lipid metabolism.
  • Targeting adipose-specific ATGL post-burn injury diminishes WAT browning, reduces fatty acids in the circulation and protects against liver dysfunction.

Open Access

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1

MLT regulated epigenetic modification of CES1 through SIRT1-mediated DNMT1 deacetylation. MLT-mediated CES1 expression induced lipid depletion, leading to ER stress-related apoptosis and blocking the intratumoral androgen synthesis that results in the inhibition of PCa progression and reversal of the enzalutamide resistance

Open Access

Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer

Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer

Overexpression of HCN provides advantages for the survival and proliferation of cancer cells. The addition of Ivabradine blocks HCN channels and affects intracellular homeostasis of Ca2+. Subsequently, this induces ER-stress and triggers apoptosis. Also, it makes the cancer cells become more sensitive to other chemotherapeutic agents.

Open Access

Glioma glycolipid metabolism: MSI2–SNORD12B–FIP1L1–ZBTB4 feedback loop as a potential treatment target

Glioma glycolipid metabolism: MSI2–SNORD12B–FIP1L1–ZBTB4 feedback loop as a potential treatment target

1. MSI2 expression was significantly upregulated in GBM, binding to SNORD12B and improving SNORD12B expression by increasing its stability.

2. SNORD12B regulated alternative polyadenylation process of transcriptional repressor ZBTB4 by competitively combining with FIP1L1.

3. ZBTB4 transcriptionally suppressed the expression of HK2, ACLY, and MSI2, forming a positive feedback regulatory loop to regulate the glycolipid metabolism and proliferation of GBM cell.

Open Access

Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

Tandem Mass Tags identified differentially expressed proteins (DEPs) between peritoneal metastasis (PM) and gastric cancer tissues, and showed that APOC2 was highly expressed in PM tissues.

APOC2 cooperates with CD36 to regulate EMT process via PI3K/AKT/mTOR signaling, which eventually promotes tumor progression and peritoneal metastasis in gastric cancer.